Skip to main content

Athenex, Inc.

ATNXDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001300699

Athenex, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on May 8, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $2.43M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
30
Q1 2023, −24 vs. previous quarter
13F value
$2.43M
Reported value at the end of Q1 2023
Superinvestors holding
0
At the end of Q1 2023

Superinvestors holding ATNX, Q1 2023

Go to the superinvestors tab

No superinvestor reported holding ATNX at the end of Q1 2023.

Latest insider trades

Open-market purchases and sales by Athenex, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 30, 2022 (view filing)6:20 PM ETAug 228 daysLateWu JinnDirectorPPurchase+10.0K$0.4221+$4.22K+2.1%484.8K after
Aug 19, 2022 (view filing)4:25 PM ETAug 19Same dayLau Johnson Yiu NamCEO and Chairman of the BoardPPurchase+20.0K$0.4549+$9.10K+0.6%3.55M after
Nov 22, 2021 (view filing)Nov 22Same dayLau Johnson Yiu NamCEO and Chairman of the BoardPPurchase+3.00K$1.84+$5.52K+0.1%3.27M after
Nov 18, 2021 (view filing)Nov 18Same dayLau Johnson Yiu NamCEO and Chairman of the BoardPPurchase+3.00K$1.87+$5.61K+0.1%3.27M after
Nov 18, 2021 (view filing)Nov 171 dayKanfer JordanDirectorPPurchase+4.95K$2.02+$10.0K+106.9%9.59K after
Nov 17, 2021 (view filing)Nov 161 dayKwan RudolfEVP, Chief Medical OfficerPPurchase+4.00K$2.05+$8.20K+2.4%173.6K after
Nov 17, 2021 (view filing)Nov 17Same dayWu JinnDirectorPPurchase+30.0K$2.03+$60.9K+7.4%433.2K after2 lots
Nov 16, 2021 (view filing)Nov 16Same dayLau Johnson Yiu NamCEO and Chairman of the BoardPPurchase+3.00K$2.06+$6.18K+0.1%3.27M after
Nov 15, 2021 (view filing)Nov 15Same dayLau Johnson Yiu NamCEO and Chairman of the BoardPPurchase+5.00K$2.12+$10.6K+0.2%3.27M after
Nov 12, 2021 (view filing)Nov 12Same dayLau Johnson Yiu NamCEO and Chairman of the BoardPPurchase+10.0K$2.07+$20.7K+0.3%3.26M after

Top 10 13F holders, Q1 2023

The largest institutional positions in Athenex, Inc. at the end of Q1 2023; share changes are against Q4 2022.

See all 30 holders
Institutions holding ATNX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC776,623$1.03M0.03%00.0%UnchangedConverted for a 1-for-20 split
Vanguard Group Inc268,160$356.7K0.00%00.0%UnchangedConverted for a 1-for-20 split
Millennium Management LLC203,861$271.0K0.00%−121,946−37.4%ReducedConverted for a 1-for-20 split
Alyeska Investment Group, L.P.100,000$133.0K0.00%00.0%UnchangedConverted for a 1-for-20 split
BlackRock Inc.66,541$88.5K0.00%00.0%UnchangedConverted for a 1-for-20 split
UBS Group AG66,337$88.2K0.00%−12,368−15.7%ReducedConverted for a 1-for-20 split
Acadian Asset Management LLC62,837$81.0K0.00%+36,664+140.1%AddedConverted for a 1-for-20 split
Renaissance Technologies LLC58,759$78.0K0.00%−1,517−2.5%ReducedConverted for a 1-for-20 split
HighTower Advisors, LLC49,827$66.0K0.00%00.0%UnchangedConverted for a 1-for-20 split
Endurant Capital Management LP42,651$56.7K0.03%−2,461−5.5%ReducedConverted for a 1-for-20 split